406 filings
Page 4 of 21
8-K
nkp1zp 70dhqtpda
17 Sep 10
Alkermes Announces FDA Advisory Committee Recommends Approval of VIVITROL(R) for Opioid Dependence
12:00am
8-K
cqkesv74
5 Aug 10
Alkermes Reports First Quarter Fiscal 2011 Financial Results
12:00am
8-K
9uo18
22 Jul 10
Departure of Directors or Certain Officers
12:00am
CT ORDER
5ak 3v2tqa
28 Jun 10
Confidential treatment order
12:00am
8-K
lc38k
13 May 10
Alkermes Reports Financial Results for Fiscal 2010 and Provides Financial Expectations for Fiscal 2011
12:00am
8-K
r0uf gqmugok
6 May 10
Regulation FD Disclosure
12:00am
8-K
bgq8mdlfayn lh
19 Apr 10
Regulation FD Disclosure
12:00am
8-K
00mytxxkgw92uks
25 Mar 10
Entry into a Material Definitive Agreement
12:00am
8-K
gssaeru
15 Mar 10
Amylin, Lilly and Alkermes Receive Complete Response Letter from Fda for Exenatide Once Weekly Submission
12:00am
8-K
mvo93xe2kx5x jopue
4 Feb 10
Results of Operations and Financial Condition
12:00am
8-K
bqbbhfw9ny3xu1 qqt
3 Dec 09
Other Events
12:00am
8-K
in3kjme9bskp9f8u3u
5 Nov 09
Results of Operations and Financial Condition
12:00am
8-K
7aqcy36fb 5ru0f9br
11 Sep 09
Departure of Directors or Certain Officers
12:00am
8-K
wudio0
26 Aug 09
Regulation FD Disclosure
12:00am
8-K
ujfrmv1x 50
6 Aug 09
Alkermes Reports First Quarter Fiscal 2010 Financial Results
12:00am